Table 4. Logistic regression analysis of the factors correlated with good clinical outcomes after treatment of CEUS-guided glenohumeral hydrodilatation.
| Factors | Univariate | Multivariate | |||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | ||
| Age (years) | 1.02 (0.93–1.12) | 0.643 | – | – | |
| Gender (male:female) | 2.13 (0.45–10.09) | 0.339 | – | – | |
| Sidedness (right:left) | 0.75 (0.17–3.33) | 0.705 | – | – | |
| Symptom duration (m) | 0.47 (0.28–0.79) | 0.004 | 0.69 (0.36–1.34) | 0.276 | |
| Initial VAS score | 2.26 (0.83–6.18) | 0.112 | – | – | |
| Initial flexion (°) | 1.07 (0.99–1.16) | 0.107 | – | – | |
| Initial abduction (°) | 1.08 (0.99–1.17) | 0.216 | – | – | |
| Initial external rotation (°) | 1.06 (0.93–1.20) | 0.378 | – | – | |
| Initial SPADI | 0.94 (0.87–1.02) | 0.129 | – | – | |
| Successful 1st attempt | 0.38 (0.05–2.69) | 0.330 | – | – | |
| Injection volume (mL) | 1.37 (1.08–1.75) | 0.011 | 1.32 (0.77–2.28) | 0.313 | |
| Massive fluid leakage | 0.052 (0.007–0.398) | 0.004 | 0.05 (0.003–0.882) | 0.041 | |
CEUS, contrast-enhanced ultrasound; OR, odds ratio; CI, confidential interval; VAS, visual analog scale; SPADI, shoulder pain and disability index.